Diploma (LON:DPLM) Price Target Raised to GBX 6,800

Diploma (LON:DPLM) had its target price boosted by Stifel Nicolaus from GBX 6,200 to GBX 6,800 in a research note issued to investors on Thursday, MarketBeat.com reports. The firm currently has a buy rating on the stock.

A number of other brokerages have also issued reports on DPLM. Peel Hunt reissued a “buy” rating and issued a GBX 6,150 price objective on shares of Diploma in a report on Friday, December 19th. Shore Capital Group reaffirmed a “hold” rating on shares of Diploma in a research note on Wednesday. Berenberg Bank reiterated a “buy” rating and set a GBX 6,350 price target on shares of Diploma in a research report on Wednesday, November 19th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Diploma from GBX 6,000 to GBX 6,200 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 6,023.75.

Diploma Price Performance

Shares of LON:DPLM opened at GBX 5,712.95 on Thursday. The firm’s 50 day moving average is GBX 5,457.51 and its two-hundred day moving average is GBX 5,425.83. Diploma has a 52 week low of GBX 3,532 and a 52 week high of GBX 6,019.52. The firm has a market capitalization of £7.66 billion, a P/E ratio of 41.61, a PEG ratio of 2.82 and a beta of 1.03. The company has a current ratio of 2.04, a quick ratio of 0.80 and a debt-to-equity ratio of 46.97.

Insider Transactions at Diploma

In related news, insider Johnny Thomson sold 30,000 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of GBX 5,668, for a total transaction of £1,700,400. Also, insider Katie Bickerstaffe bought 352 shares of the company’s stock in a transaction that occurred on Wednesday, January 14th. The shares were purchased at an average cost of GBX 5,645 per share, for a total transaction of £19,870.40. Company insiders own 1.14% of the company’s stock.

Diploma News Roundup

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Surprise profit upgrade forced a re‑rating of consensus and sparked a ~17% share jump as investors digested stronger-than-expected guidance. Diploma shares surge 17% as surprise profit upgrade exposes the bearish consensus
• Positive Sentiment: Guidance upgrade lifted Diploma’s earnings forecasts (~15%) and prompted price-target increases (headline 6,600p), reinforcing the bullish re-rate. Diploma price target lifted to 6,600p after guidance upgrade drives 15% earnings forecast rise
• Positive Sentiment: Berenberg raised its price target sharply to GBX 7,500 and moved to a “buy” rating, signaling confidence in the upgraded outlook. Broker ratings
• Positive Sentiment: Stifel increased its target to GBX 6,800 and upgraded to “buy”, adding to the cluster of upward revisions from brokers. Broker ratings
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and now carries a “buy” stance, supporting the upward momentum. Broker ratings
• Positive Sentiment: Royal Bank of Canada lifted its target to GBX 6,600 and set an “outperform” rating — another well‑known house backing the upgraded story. RBC note
• Negative Sentiment: Shore Capital reaffirmed a “hold” rating on 20 March, which may have damped some of the rally and encouraged profit‑taking after the sharp run. Shore Capital Group Reaffirms Hold Rating for Diploma

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.